Befejeződött1. fázis
A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of ACD856 in healthy participants
Key facts
- Where
- Uppsala, SvédországSee the site
- Phase
- 1. fázis
Where in Svédország
- CTC Clinical Trial Consultants ABUppsala, SvédországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AlzeCure Pharma AB
- Trial code
- EU 2025-522287-32-00
- Record updated
- 2025. szeptember 10.